Corrigendum: The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China - Li, Lu; Yang, Shilei; Fang, Fengqi; Tian, Li; He, Ying; Li, Jia; Chen, Yanwei; Dong, Deshi (Frontiers in Pharmacology, 2024)